Community pharmacy contractors that fully meet the requirements for provision of the Community Pharmacy Seasonal Influenza Vaccination Advanced Service now have the go ahead to provide the service from 1st September 2017. This follows the amendment of the Secretary of State Directions. . A link to the Secretary of State Directions, which provide the legal basis for provision of the service is available from the flu vaccination section of the PSNC website. Contractors should read PSNC Briefing 055/17: Guidance on the Seasonal Influenza Vaccination Advanced Service 2017/18 (in addition to the service specification and Patient Group Direction) as this provides detailed advice on what contractors need to have in place before providing the service. Commenting on the publication of the Directions, Alastair Buxton, Director of NHS Services at PSNC, said: “The completion of the regulatory changes means community pharmacy teams can now start offering the NHS Flu Vaccination Service to eligible patients from the 1st September. I hope that pharmacy teams will really get behind this important service, like they did last year, to show patients and the NHS just what community pharmacy is capable of." Further resources available on the PSNC WebsiteDetailed guidance, including a checklist which contractors can print out and work through to ensure they have everything they need in place to successfully provide the service. Flu Training LPC's accross the region have put on many training sessions over the summer to ensure pharmacists are ready for this years service. We have trained approx 300 pharmacists. These training sessions are now complete however we may be able to run a further mop up session if the demand is there. Please click here if you still require training to register your interest. Please note we will only be able to run a further session if it numbers are viable.
0 Comments
Community pharmacy contractors* across England will recently have received emails from NHS England asking them to participate in the first ever national community pharmacy workforce survey. If a pharmacy contractor has not received an email regarding the survey from NHS England, they should email [email protected]. The online questionnaire about the pharmacists, pharmacy technicians, medicines counter and dispensary workforce in each pharmacy is being conducted for Health Education England (HEE). The survey is designed to inform the commissioning of future education and development programmes for community pharmacists, pharmacy technicians and the wider team. To complete the survey, contractors should use the unique, secure log-in, they will have received by email, to access the survey. Contractors have until 30th September 2017 to complete the survey. Commenting on the launch of the survey, Alastair Buxton, Director of NHS Services at PSNC said: “We encourage all contractors to complete the survey. This is the first ever national workforce survey and the data collected through it will inform future commissioning of clinical education and development of the whole pharmacy team. Additional education and development for the whole pharmacy team will support the sector’s ambition to radically enhance and expand the personalised care, support and wellbeing services that community pharmacies provide, as described in the Community Pharmacy Forward View. It is therefore important that contractors complete the survey so that HEE has the information it needs to properly plan future training and development initiatives.” Please Note * Asda, Boots, Lloyds, Morrisons, Rowlands, Superdrug, Tesco, and Well have already completed the survey centrally, so pharmacies within those companies will not receive a request to complete the survey. Further information on the surveyHEE is the national leadership organisation for education, training and workforce development in the health sector. It works to ensure the workforce has the right skills, behaviours and training, and is available in the right numbers, to support the delivery of excellent healthcare and drive improvements. For example, HEE funds the work of the Centre for Pharmacy Postgraduate Education (CPPE). This is one of several schemes linked to further clinical education and development for pharmacists and pharmacy technicians which have been commissioned by HEE working in collaboration with NHS England. The wider schemes, which will be informed by the community pharmacy workforce survey, will be funded by an initial £15 million investment from the Pharmacy Integration Fund up to March 2019. The survey is being undertaken by an independent research company called Marketing Means (UK) Ltd, and NHS England will send the survey invitation (on behalf of HEE) by email directly to contractors. This will contain a clickable link which will take contractors straight to the questionnaire, which is hosted on a secure website. For most pharmacies, the questionnaire should take approximately 15 minutes to complete. HEE have developed a crib sheet which can be used to collate information on pharmacy staff before you complete the online questionnaire: Workforce survey crib sheet Potential ways in which the data might be used by HEE are:
In the case of pharmacies which are part of a group, HEE will report survey participation and non-participation to the group’s head office, if requested to do so. If you have any queries, please contact:
We would like to bring to the attention of pharmacy staff that Midazolam injection - for safety reasons and as part of the palliative care guidelines should normally be prescribed as the 10mg/2ml. Occasionally the "wrong strength" has been prescribed and pharmacists are asked to query strengths where appropriate in palliative care patients. Catherine Baldridge, medication safety officer, based at South Tyneside Trust said "Community nurses are continuing to report some prescribing of the ‘wrong strength’ of midazolam. Instead of prescribing the 10mg in 2ml as recommended in palliative patients they are prescribing the 1mg in 1ml preparation or the 10mg in 5ml. We have had one error where the patient got the wrong dose administered. The reason that the 10mg in 2ml should be prescribed/dispensed is because of the volume issue with the more dilute preparations. The usual starting dose of midazolam is 2.5mg and is increased from there – the dose will be administered sub-cutaneously and therefore the concentrated preparation needs to be used to reduce the volume required". |
Copies of our older Paper Based News Letters (The LPC News) can be found by clicking below.
Categories
All
|